Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...
© 2026 Forbes Media LLC. All Rights Reserved.
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of ...
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. David Kindness is a Certified Public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results